Innovative Automated Insulin Delivery System for Type 2 Diabetes
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 307 participants.
Also called NCT06853990
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 307 participants
- Sponsor
- Deka Research and Development
- Registry
-
NCT06853990
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT06853990. Allocation not applicable; no masking; primary purpose treatment. Start 2025-04-14 (actual); primary completion 2026-02-25 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Innovative Automated Insulin Delivery System for Type 2 Diabetes
- Acronym
- twiist-T2D
- Condition
- Type 2 Diabetes
- Condition
- Insulin Treated Type 2 Diabetes Mellitus
- Intervention (Device)
- twiist insulin delivery system
- Lead sponsor
- Deka Research and Development
- Collaborator
- Sequel Med Tech
Record details
- Record id
cardio:ct-nct06853990- Content hash
1cc7fb1e674103c84f4571ee4575f2023a915acadd1698094293064a3a764b8f